TXG β€” 10X GENOMICS INC

Ownership history in Bridgefront Capital, LLC  Β·  4 quarters on record

This page tracks every 13F SEC filing in which Bridgefront Capital, LLC reported a position in 10X GENOMICS INC (TXG). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.29% (2024 Q1)
πŸ“Š Avg. % of fund
0.16%
πŸ“… First filed
2020 Q4
πŸ“… Last filed
2025 Q3
⏱ Quarters held
4

Position Intelligence

Bridgefront Capital, LLC Γ— TXG AI Analytics

πŸ“‰ Bridgefront Capital, LLC underperformed the S&P 500 by –231.9% annually on this TXG position. Timing score: 0% (0/3 decisions correct). Average cost basis: $37.79. Maximum drawdown during holding period: –91.7%.

πŸ“ˆ Position Alpha vs SPY
-231.9%
annualised excess return

❌ Significantly underperformed the S&P 500 by 231.9% ann.
2 quarters analyzed

⏱️ Timing Score
0%

⚠️ Poor timing β€” buys often preceded drops, trims preceded rallies.
0 of 3 add/trim decisions correct

πŸ’° Entry Quality
$37.79
-69.1% vs current ($11.69)

Best entry: $11.69 (2025 Q3)  Β·  Worst: $141.60 (2020 Q4)

πŸ›‘οΈ Drawdown Resilience
–91.7%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
100%
buy-side decisions

4 adds Β· 0 trims. Bought during 3 of 3 down-price quarters. πŸ‚ Consistently bullish β€” fund kept accumulating this position.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.08% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    TXG price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 4 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 24,431 +11,597 +90.4% 0.08% $286K $11.69
2024 Q3 ADDED 12,834 +2,549 +24.8% 0.11% $290K $22.58
2024 Q1 ADDED 10,285 +6,978 +211.0% 0.29% $386K $37.53
2020 Q4 INITIATED 3,307 β€” β€” 0.16% $468K $141.60

🏒 Other funds also holding TXG

As of 2025 Q4 β€” sorted by position size

Freshford Capital Management, LLC 3Y 7Y 5.45% Tao Capital Management LP 3Y 2.96% ARCH Venture Management, LLC 3Y 7Y 1.85% Quantedge Capital Pte Ltd 3Y 1.59% Sands Capital Alternatives, LLC 3Y 1.52% Casdin Capital, LLC 3Y 7Y 1.42% ARK Investment Management LLC 3Y 7Y 1.37% Exome Asset Management LLC 1.28% Amova Asset Management Americas, Inc. 3Y 7Y 1.03% CLOUGH CAPITAL PARTNERS L P 3Y 7Y 0.88%
← Back to Bridgefront Capital, LLC Holdings